SignalCorporate
Merck outlines 2026 revenue of $66.8B-$67.3B and EPS of $2.77-$2.82 while investing ahead of KEYTRUDA LOE
Merck guides 2026 revenue $66.8B–$67.3B and EPS $2.77–$2.82 while investing ahead of KEYTRUDA LOE.
What changed
Merck guides 2026 revenue $66.8B–$67.3B and EPS $2.77–$2.82 while investing ahead of KEYTRUDA LOE.
Why it matters
Merck guides 2026 revenue $66.8B–$67.3B and EPS $2.77–$2.82 while investing ahead of KEYTRUDA LOE. — impact context not separately stored; see What changed.